Noman Omar M, Mothana Ramzi A, Al-Rehaily Adnan J, Al Qahtani Ali S, Nasr Fahd A, Khaled Jamal M, Alajmi Mohamed F, Al-Said Mansour S
Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Departments of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Saudi Pharm J. 2019 Jul;27(5):724-730. doi: 10.1016/j.jsps.2019.04.008. Epub 2019 Apr 20.
The genus has been demonstrated to be used in the treatment of wide range of diseases e.g. diabetes, inflammations and cancers. Many species of represent a major source of biologically active constituents. Therefore, our study was carried out to investigate the anti-diabetic, anti-inflammatory and antioxidant effects of Zucc. (Loranthaceae) grown in Saudi Arabia. Moreover, our research concerned the guided-fractionation and isolation of possible active compounds from this species. The crude ethanolic extract and its hexane, chloroform and -butanol fractions were investigated for antidiabetic activity utilizing two methods namely, in alloxan-induced diabetic rats and glucose tolerance test in normal rats. Additionally, the anti-inflammatory activity was studied by the carrageenan-induced rat paw oedema method while DPPH free radical scavenging and -carotene bleaching assays were utilized to determine the antioxidant activity. Various chromatographic and spectroscopic techniques were utilized for the isolation and characterization of the active compounds. Our results exhibited that the crude extract and chloroform fraction has the greatest hypoglycemic and antidiabetic effects. The chloroform fraction and crude extract produced at a dose of 500 mg/kg a significant hypoglycemic effect in diabetic rats with 47.0 and 33.6% reduction in blood sugar levels and in normoglycemic rats 35.6 and 35.4% respectively. A potent anti-inflammatory effect (67.2% at 500 mg/kg) was detected for the chloroform fraction. In addition, the chloroform fraction exhibited a high antioxidative and DPPH-radical inhibitory activity (85.4 and 88.3% respectively). The phytochemical analysis of led to the isolation and characterization of four compounds namely, quercetin 3---D-glucopyranoside (compound ), quercetin 3---(6--galloyl)-glucopyranoside (compound ), (-) catechin (compound ), and catechin 7--gallate (compound ). Among these compounds quercetin 3---D- glucopyranoside, quercetin 3-6--galloyl)-glucopyranoside and catechin 7--gallate, are isolated for the first time from this plant.
该属植物已被证明可用于治疗多种疾病,如糖尿病、炎症和癌症。许多该属物种是生物活性成分的主要来源。因此,我们开展了这项研究,以调查生长在沙特阿拉伯的扁枝槲寄生(檀香科)的抗糖尿病、抗炎和抗氧化作用。此外,我们的研究还涉及从该物种中对可能的活性化合物进行导向分级分离和提纯。利用两种方法,即对四氧嘧啶诱导的糖尿病大鼠和正常大鼠进行葡萄糖耐量试验,研究了粗乙醇提取物及其己烷、氯仿和正丁醇馏分的抗糖尿病活性。此外,通过角叉菜胶诱导的大鼠足爪水肿法研究了其抗炎活性,同时利用DPPH自由基清除和β-胡萝卜素漂白试验来测定抗氧化活性。采用各种色谱和光谱技术对活性化合物进行分离和表征。我们的结果表明,粗提取物和氯仿馏分具有最大的降血糖和抗糖尿病作用。氯仿馏分和粗提取物在500mg/kg剂量下,对糖尿病大鼠产生了显著的降血糖作用,血糖水平分别降低了47.0%和33.6%,对正常血糖大鼠分别降低了35.6%和35.4%。氯仿馏分检测到有强大的抗炎作用(500mg/kg时为67.2%)。此外,氯仿馏分表现出高抗氧化和DPPH自由基抑制活性(分别为85.4%和88.3%)。对扁枝槲寄生的植物化学分析导致分离和鉴定了四种化合物,即槲皮素3-O-β-D-吡喃葡萄糖苷(化合物1)、槲皮素3-O-(6-O-没食子酰)-吡喃葡萄糖苷(化合物2)、(-)-儿茶素(化合物3)和儿茶素7-O-没食子酸酯(化合物4)。在这些化合物中,槲皮素3-O-β-D-吡喃葡萄糖苷、槲皮素3-(6-O-没食子酰)-吡喃葡萄糖苷和儿茶素7-O-没食子酸酯是首次从该植物中分离得到。